CCND1 and lip and oral cavity carcinoma: The proposed mechanism of therapeutic resistance to EGFR TKIs include constant stimulation of downstream signaling pathways by mutated RAS gene in oral cancer via special group of genes such as CCND1, c-MYC, BCL-XL and BCL-2 [93].